Skip to main content
Fig. 2 | BMC Pregnancy and Childbirth

Fig. 2

From: A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt

Fig. 2

Non-inferiority test. Both the point estimate and one 95% confidence interval for change in pre- and post-delivery hemoglobin falls above the a priori-defined non-inferiority margin of -0.3, indicating that secondary prevention is non-inferior to primary prevention. Abbreviations: CI=Confidence interval, Hb = hemoglobin, SP = secondary prevention, PP = primary prevention

Back to article page